1. Kiyoharu Ukai S,Chiharu Masuda M,Satoko Kubo O,Teruo Mukai J,Terutake Nakagawa O.1990. Use of N,N-dimethyl-1-[1-(4-chlorophenyl)-cyclobutyl]-3-methylbutylamine. US patent No4,939,175.
2. Kozlik A,Wilmshurst EC,Jefferey JE.1982. Therapeutic agents. GB patent No2,098,602.
3. Sibutramine: A review of its contribution to the management of obesity;McNeely;Drugs,1998
4. Monoamine reuptake inhibitors: Highlights of recent research development;Walter;Drug Dev Res,2005
5. Pharmacotherapy for obesity;Ioannides-Demos;Drugs,2005